Share-based Compensation - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jan. 16, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Options outstanding (in shares) | 1.0 | ||
| Weighted average exercise price (in dollars per share) | $ 32.91 | ||
| Unrecognized compensation expense, options | $ 1.9 | ||
| Compensation expense, recognition period | 2 years 4 months 24 days | 2 years 6 months | |
| Employee Stock Option | |||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Compensation expense, recognition period | 2 years 6 months | ||
| Semler Scientific, Inc. 2014 Stock Option And Incentive Plan | |||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Options assumed (in shares) | 0.4 | ||
| Semler Scientific, Inc. 2024 Stock Option And Incentive Plan | |||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Options assumed (in shares) | 0.6 |
| X | ||||||||||
- Definition Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Assumed In Period No definition available.
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|